Evidence map›Paper›PMID 30158716›Full record

ArticleGeburtshilfe und Frauenheilkunde2018

Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis.

Philip Junker, Julian Puppe, Fabinshy Thangarajah, Christian Domröse, Angela Cepic, Bernd Morgenstern, Dominik Ratiu, Martin Hellmich, Peter Mallmann, Marina Wirtz

Open access · hybridAbstract read
In one paragraph

Article in Geburtshilfe und Frauenheilkunde, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Philip JunkerUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Julian PuppeUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Fabinshy ThangarajahUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Christian DomröseUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Angela CepicUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Bernd MorgensternUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Dominik RatiuUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Martin HellmichUniklinik Köln, Institut für Medizinische Statistik, Informatik und Epidemiologie, Köln, Germany.
Peter MallmannUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Marina WirtzUniklinik Köln, Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Köln, Germany.
Klinik und Poliklinik für Urologie · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bevacizumabcervical cancerneoadjuvant chemotherapyVEGF antibody

Identifiers

PMID30158716
PMCPMC6109715
OpenAlexW2889002961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.